Multidrug Regimen Appears Feasible for Older Patients With Advanced Hodgkin Lymphoma

By News Health
12 hours Ago

(MedPage Today) — A multidrug regimen containing brentuximab vedotin (BV, Adcetris) proved feasible for older patients with advanced classical Hodgkin lymphoma (cHL), with outcomes similar to younger patients but with a significant toxicity cost…

Source link : https://www.medpagetoday.com/hematologyoncology/lymphoma/116626

Author :

Publish date : 2025-07-22 20:18:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Are Preschoolers in the US Meeting Healthy Behavior Goals?

How Docs Are Redesigning Their Office for Patient Comfort

Pop star Ella Henderson reveals endometriosis diagnosis

How Myeloma Plays Hide and Seek With CAR T Cells

Key Drivers of High Costs in Head and Neck Cancer Care

Ancient ‘terror birds’ may have been no match for hungry giant caimans